24May 2023
Liraglutide versus semaglutide for weight reduction—a cost needed to treat analysis

Liraglutide versus semaglutide for weight reduction—a cost needed to treat analysis

This study aimed to compare the cost-effectiveness of the glucagon-like peptide-1 agonists liraglutide and semaglutide in achieving weight reduction. Data from the STEP 1 trial for liraglutide and the SCALE trial for semaglutide were used. Liraglutide resulted in a 5.4% weight loss, while semaglutide led to a more substantial 12.4% weight loss. The estimated total cost of therapy during the trials was $17,585 for liraglutide and $22,878 for semaglutide. The cost needed to treat per 1% of body weight reduction was estimated at $3,256 for liraglutide and $1,845 for semaglutide. Thus, semaglutide was found to provide better value for money in terms of weight reduction compared to liraglutide.

  • #endo-diabetology

Like

Save

Share